104776-70-7

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 5-ACETYLISOXASOLE-3-CARBOXYLATE is used as a key intermediate in the synthesis of pharmaceutical drugs. Its high purity and stability contribute to the development of effective and safe medications, enhancing the overall quality of healthcare products.
Used in Agricultural Industry:
In the agricultural sector, ETHYL 5-ACETYLISOXASOLE-3-CARBOXYLATE serves as an essential component in the production of agrochemicals. Its role in creating effective and stable agrochemicals helps improve crop protection and yield, contributing to sustainable agriculture practices.
Used in Organic Synthesis:
ETHYL 5-ACETYLISOXASOLE-3-CARBOXYLATE is utilized as a vital intermediate in organic synthesis, enabling the creation of a diverse range of chemical compounds. Its versatility and stability make it a valuable asset in the development of new and innovative products across various industries.
Used in Biological and Medicinal Product Production:
ETHYL 5-ACETYLISOXASOLE-3-CARBOXYLATE is also used as a key constituent in the production of various biological and medicinal products. Its presence in these products ensures high-quality standards and contributes to advancements in the fields of biology and medicine.

InChI:InChI=1/C8H9NO4/c1-3-12-8(11)6-4-7(5(2)10)13-9-6/h4H,3H2,1-2H3

Upstream product

• 1423-60-5 methyl ethynyl ketone 
• 14337-43-0 ethyl 2-chloro-2-(hydroxyimino)acetate 
• 78934-71-1 ethyl 5-(1-hydroxyethyl)isoxazole-3-carboxylate 

Downstream Products

• 145441-17-4 5-acetyl-3-isoxazolecarboxylic acid 
• 104776-74-1 ethyl 5‐(2‐bromoacetyl)isoxazole‐3‐carboxylate 
• 131974-27-1 5-(2,2-Dibromo-acetyl)-isoxazole-3-carboxylic acid ethyl ester 
• 139297-29-3 N-(2,6-dimethylphenyl)-5-acetyl-3-isoxazolecarboxamide 

Relevant academic research and scientific papers

Synthesis of 5-(Fluoroalkyl)isoxazole Building Blocks by Regioselective Reactions of Functionalized Halogenoximes

A comprehensive study on the synthesis of 5-fluoroalkyl-substituted isoxazoles starting from functionalized halogenoximes is reported. One-pot metal-free [3 + 2] cycloaddition of CF3-substituted alkenes and halogenoximes bearing ester, bromo, c

Discovery of substituted (2‐aminooxazol‐4‐yl)isoxazole‐3‐ carboxylic acids as inhibitors of bacterial serine acetyltransferase in the quest for novel potential antibacterial adjuvants

Many bacteria and actinomycetales use L‐cysteine biosynthesis to increase their tolerance to antibacterial treatment and establish a long‐lasting infection. In turn, this might lead to the onset of antimicrobial resistance that currently represents one of

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery

Tuberculosis remains one of the deadliest infectious diseases in the world, and the increased number of multidrug-resistant and extremely drug-resistant strains is a significant reason for concern. This makes the discovery of novel antitubercular agents a cogent priority. We have previously addressed this need by reporting a series of substituted 2-aminothiazoles capable to inhibit the growth of actively replicating, nonreplicating persistent, and resistant Mycobacterium tuberculosis strains. Clues from the structure-activity relationships lining up the antitubercular activity were exploited for the rational design of improved analogues. Two compounds, namely N-phenyl-5-(2-(p-tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 7a and N-(pyridin-2-yl)-5-(2-(p-tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 8a, were found to show high inhibitory activity toward susceptible M. tuberculosis strains, with an MIC90 of 0.125-0.25 μg/mL (0.33-0.66 μM) and 0.06-0.125 μg/mL (0.16-0.32 μM), respectively. Moreover, they maintained good activity also toward resistant strains, and they were selective over other bacterial species and eukaryotic cells, metabolically stable, and apparently not susceptible to the action of efflux pumps.

MALONONITRILE COMPOUND AS PESTICIDES

The present invention provides a malononitrile compound represented by the formula (I): wherein any one of X1, X2, X3 and X4 is CR100, wherein R100 is a group represented by the formula: the other three of X1, X2, X3 and X4 each represent nitrogen or CR5, provided that 1 to 3 of X1, X2, X3 and X4 represent nitrogen, and Z represents oxygen, sulfur or NR6, which has pest-controlling activity.

Synthesis and pharmacological characterization of new analogs of broxaterol

A series of isoxazole derivatives structurally related to broxaterol 1 has been prepared and tested for their potency to β1 and β2 adrenergic receptors. At variance with broxaterol, none of the tested compounds displayed agonistic activity. The 3-isopropenyl derivative 5f is the most potent antagonist both in the trachea and atria preparations.

N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents

A series of N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives was synthesized and tested on the passive cutaneous anaphylaxis (PCA) model in rats to verify its potential antianaphylactic activity. These compounds were prepared by reaction of an appropri

4-(isoxazolyl)-thiazole-2-oxamic acids and derivatives thereof

4-(isoxazolyl)-thiazole-2-oxamic acids, esters and salts thereof; method for preparing them and intermediate compounds useful for their preparation. Said compounds possess antiallergic and antianaphylactic activity and may be used in the pharmaceutica